Phase 2 trial of durvalumab and radiation revaccination in patients with metastatic adenocarcinoma of the pancreas who have progressed through first-line chemotherapy. Article

Chuong, Michael David, Badiyan, Shahed Nicolas, Mehta, Minesh P. (2019). Phase 2 trial of durvalumab and radiation revaccination in patients with metastatic adenocarcinoma of the pancreas who have progressed through first-line chemotherapy. . JOURNAL OF CLINICAL ONCOLOGY, 37(4_suppl), tps461-tps461. 10.1200/jco.2019.37.4_suppl.tps461

cited authors

  • Chuong, Michael David; Badiyan, Shahed Nicolas; Mehta, Minesh P

authors

publication date

  • February 1, 2019

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3204 Immunology
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • 6.2 Cellular and gene therapies
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Digestive Diseases
  • Immunization
  • Pancreatic Cancer
  • Prevention
  • Rare Diseases
  • Vaccine Related

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • tps461

end page

  • tps461

volume

  • 37

issue

  • 4_suppl